![]() |
市场调查报告书
商品编码
1439313
全球颅耳电疗刺激器市场:洞察、竞争格局、市场预测:2030 年Cranial & Auricular Electrotherapy Stimulation Devices - Market Insights, Competitive Landscape, and Market Forecast - 2030 |
预计 2024 年至 2030 年预测期内,全球颅脑和耳廓电疗刺激器市场规模将以 6.2% 的复合年增长率成长。对颅脑和耳廓电疗刺激器的需求不断增加,主要是由于各种精神和精神疾病的盛行率上升、全球慢性疼痛病例的增加以及人口中失眠症盛行率的增加。此外,主要製造商增加研发投资以及设备开发的各种临床试验的进展预计将推动颅脑和耳廓电疗刺激器市场的发展。
颅耳电疗刺激器是一种小型设备,使用小于 4mA 的电流来活化大脑和颅骨,以治疗焦虑、忧郁、疼痛等。忧郁症、躁郁症、精神分裂症、失智症和其他精神疾病等精神疾病的日益普及预计将急剧增加对颅耳电疗刺激器的需求。根据世界卫生组织 (WHO) 2019 年的报告,大约有 2.64 亿人患有忧郁症,使其成为全球常见的精神障碍之一,也是导致残疾的主要原因。
此外,慢性疼痛在人群中日益流行也是颅脑和耳廓电疗刺激器市场的驱动因素。例如,根据美国疾病管制与预防中心(CDC)2019年的数据,约20.4%的成年人口患有慢性疼痛,至少7.4%的成年人患有影响日常生活和工作的慢性疼痛。我患有慢性疼痛,这常常限制我的活动。
因此,上述因素可能是全球颅脑和耳廓电疗刺激器市场的潜在驱动力。
该报告研究了全球颅骨和耳廓电疗刺激器市场,并提供了市场概述,包括按产品类型、最终用户、地区和参与市场的公司概况划分的趋势。
Cranial & Auricular Electrotherapy Stimulation Devices Market By Product Type (Cranial Electrostimulation Devices And Auricular Electrostimulation Devices), By Application (Insomnia, Depression, Anxiety, Pain Management, And Others), By Geography is projected to expand at a significant CAGR forecast till 2030 owing to rising prevalence of mental & psychiatric disorders and growing demand for electrostimulation devices as an alternative option for treatment.
Global Cranial & Auricular Electrotherapy Stimulation Devices Market will grow at a CAGR of 6.2% during the forecast period of 2024-2030. The rise in demand for Cranial & Auricular Electrotherapy Stimulation Devices is primarily due to the rising prevalence of various mental and psychiatric disorders, increase in chronic pain cases across the globe, increasing insomnia among the population. Moreover, the rise in research and development investment by key manufacturers along with various ongoing clinical trials for device development are other factors expected to boost the market for cranial & auricular electrotherapy stimulation devices.
Cranial & Auricular Electrotherapy Stimulation Devices Market Dynamics:
Cranial and auricular electrotherapy devices are small devices that use a current of less than 4 mA for activating the brain and cranium for the treatment of anxiety, depression, pain, and others. The growing prevalence of mental disorders such as depression, bipolar disorder, schizophrenia, dementia, and other psychoses is expected to surge the demand for cranial and auricular electrotherapy stimulation devices. According to the World Health Organization (WHO) 2019 report, approximately 264 million people were affected by depression which is one of the common mental disorders and also the leading cause of disability worldwide.
In addition, the increasing prevalence of chronic pain among the population is also a driving factor for the cranial & auricular electrotherapy stimulation devices market. For instance, as per the Center for Disease Control and Prevention (CDC) 2019 data, approximately 20.4% of the adult population suffered from chronic pain and at least 7.4% of adults had high impact chronic pain (chronic pain that frequently limits life or work activities).
Thus, the above-mentioned factors could be potential driving factors for the global cranial & auricular electrotherapy stimulation devices market
However, the high cost of the cranial & auricular electrotherapy stimulation devices and lack of awareness regarding these devices may pose a minor hurdle for the growth of the Cranial & Auricular Electrotherapy Stimulation Devices market.
Cranial & Auricular Electrotherapy Stimulation Devices Segment Analysis:
Cranial & Auricular Electrotherapy Stimulation Devices Market By Product Type (Cranial Electrostimulation Devices and Auricular Electro-Stimulation Devices), By Application (Insomnia, Depression, Anxiety, Pain Management, and Others), and by Geography (North America, Europe, Asia-Pacific, and Rest of the World).
In the Cranial & Auricular Electrotherapy Stimulation Devices product segment, Cranial Stimulation Devices is anticipated to hold the largest market during the forthcoming years. This is owing to the rising research and development, and ongoing clinical trials for the development of devices for extended indications such as post-traumatic stress disorder, major depressive disorder, drug abuse, among others. For instance, Electromedical Products International, Inc. has initiated a clinical trial in the year 2017 to study the efficacy of cranial electrotherapy stimulation for the treatment of the major depressive disorder. The study is expected to complete in the year 2023.
Moreover, significant product approvals in the devices portfolio are also anticipated to spur the market. For instance, DyAnsys, Inc. received FDA approval for Drug Relief, a percutaneous nerve field stimulator system indicated to treat opioid withdrawal symptoms by electrically stimulating the cranial nerves.
In addition, rising substance use disorder could also be a potential driving factor for the cranial and auricular electrotherapy stimulation devices market growth. According to the United Nations Office on Drugs and Crime (UNODC) 2020 report, an estimated 269 million used drugs worldwide in 2018 and over 35 million people suffered from drug abuse disorders.
North America is expected to dominate the overall Cranial & Auricular Electrotherapy Stimulation Devices Market:
Among all the countries, North America is expected to dominate the overall Cranial & Auricular Electrotherapy Stimulation Devices market during the forecast period. This domination is due to the rising government initiatives to spread awareness regarding mental health disorders, sleeping disorders, and others. In addition, the presence of an advanced healthcare system is also likely to augment the market for cranial & auricular electrotherapy stimulation devices in the region
Further, in the United States, the rising cases of anxiety among the population could also contribute to the demand for cranial and auricular electrotherapy stimulation devices. For instance, as per the 2022 data of The Anxiety and Depression Association of America (ADAA), an international nonprofit organization approximately 6.8 million of the US population are affected with generalized anxiety disorder, and around 15 million of the population are affected by social anxiety disorder.
Moreover, reclassification of cranial electrotherapy stimulator devices intended to treat anxiety and/or insomnia from class III to Class II medical devices by the US Food and Drug Administration in the year 2019 could also bolster the market for cranial & auricular electrotherapy stimulation devices in the region.
In addition, the rising incidence of stress among the population of Canada is also anticipated to augment the market for these devices. For instance, as per the report of the Statistic Canada 2022, there approximately 6,560,500 population of age 12 years and above were suffering from stress in the year 2020. Thus, these factors will contribute to the market growth of cranial and auricular electrotherapy stimulation devices in the region.
Also, the Asia-Pacific region has the future potential growth for the Global Cranial & Auricular Electrotherapy Stimulation Devices. The presence of various NGOs and rising government initiatives to raise awareness regarding mental disorders is projected to augment the demand for these devices in the region. For instance, the Government of India launched the National Mental Health Programme (NMHP) in 1982 which has recently passed the Mental Health Care Act 2017 which came into force from July 07, 2018, mainly focused on treatment, rehabilitation, and raising awareness regarding the mental health disorder.
Furthermore, rising disposable income, improving healthcare facilities, and the increasing population suffering from mental disorders will contribute to the cranial and auricular electrotherapy stimulation devices market growth. According to the Australian Bureau of Statistics (ABS) National Survey of Mental Health and Wellbeing (NSMHWB) 2019 data, approximately 4.8 million Australians were suffering from a mental or behavioral condition in the year between 2017 to 2018.
Hence, all the aforementioned factors will provide lucrative opportunities for the market growth of cranial & auricular electrotherapy Stimulation devices in the region during the forecasted period.
Cranial & Auricular Electrotherapy Stimulation Devices Market Key Players:
Some of the key market players operating in the Cranial & Auricular Electrotherapy Stimulation Devices market include DyAnsys Inc, Neuro-Fitness LLC, Electromedical Products International, Inc., INNOVATIVE NEUROLOGICAL DEVICES, Fisher Wallace, Johari Digital, SzeleSTIM GmbH, Soterix Medical Inc, Brainbox Ltd, neurocare group AG, Parasym Ltd, Neuroelectrics, Masimo, Innovative Health Solutions INC, Biegler GmbH, Ybrain, INC, NEUROSANTE, Cefaly, and others.
Recent Developmental Activities in the Cranial & Auricular Electrotherapy Stimulation Devices Market:
In March 2019, Innovative Neurological Devices LLC received FDA approval for Cervella Cranial Electrotherapy Stimulator (CES) indicated for the treatment of insomnia, depression, or anxiety.
Key Takeaways from the Cranial & Auricular Electrotherapy Stimulation Devices Market Report Study
Market size analysis for current market size (2023), and market forecast for 5 years (2024-2030)
The effect of the COVID-19 pandemic on this market is significant. To capture and analyze suitable indicators, our experts are closely watching the Cranial & Auricular Electrotherapy Stimulation Devices market.
Top key product/services/technology developments, merger, acquisition, partnership, joint venture happened for last 3 years
Key companies dominating the Global Cranial & Auricular Electrotherapy Stimulation Devices Market.
Various opportunities available for the other competitor in the Cranial & Auricular Electrotherapy Stimulation Devices Market space.
What are the top-performing segments in 2023? How these segments will perform in 2030.
Which are the top-performing regions and countries in the current market scenario?
Which are the regions and countries where companies should have concentrated on opportunities for Cranial & Auricular Electrotherapy Stimulation Devices market growth in the coming future?
Target Audience who can be benefited from the Cranial & Auricular Electrotherapy Stimulation Devices Market Report Study
Cranial & Auricular Electrotherapy Stimulation Devices providers
Research organizations and consulting companies
Cranial & Auricular Electrotherapy Stimulation Devices-related organization, association, forum, and other alliances
Government and corporate offices
Start-up companies, venture capitalists, and private equity firms
Distributors and Traders in Cranial & Auricular Electrotherapy Stimulation Devices
Various End-users who want to know more about the Cranial & Auricular Electrotherapy Stimulation Devices Market and the latest technological developments in the Cranial & Auricular Electrotherapy Stimulation Devices market.
Frequently Asked Questions for the Cranial & Auricular Electrotherapy Stimulation Devices Market:
Cranial & Auricular Electrotherapy Stimulation Devices are the devices that deliver weak electrical pulses to the scalp or ear lobes for treating various diseases such as chronic pain, depression, anxiety among others.
Global Cranial & Auricular Electrotherapy Stimulation Devices Market will grow at a CAGR of 6.2% during the forecast period of 2024-2030.
The major factors driving the demand for Cranial & Auricular Electrotherapy Stimulation Devices are the growing prevalence of various mental health and psychotic disorder such as depression, anxiety, stress, among others, increase in insomnia cases, and growing prevalence of chronic pain. Moreover, an increase in research and development is also likely to propel the cranial and auricular electrotherapy stimulation market.
Some of the key market players operating in the Cranial & Auricular Electrotherapy Stimulation Devices market include DyAnsys Inc, Neuro-Fitness LLC, Electromedical Products International, Inc., INNOVATIVE NEUROLOGICAL DEVICES, Fisher Wallace, Johari Digital, SzeleSTIM GmbH, Soterix Medical Inc, Brainbox Ltd, neurocare group AG, Parasym Ltd, Neuroelectrics, Masimo, Innovative Health Solutions INC, Biegler GmbH, Ybrain, INC , NEUROSANTE , Cefaly, and others.
North America is expected to dominate the overall Cranial & Auricular Electrotherapy Stimulation Devices market during the forecast period. This domination is due to the rising government initiatives to spread awareness regarding mental health disorders, sleeping disorders, and others. In addition, the presence of an advanced healthcare system is also likely to augment the market for cranial & auricular electrotherapy stimulation devices in the region.